Embryo Ventures
VC Fund
London, United Kingdom
Embryo Ventures is a London-based venture firm that backs the world's most exceptional founders building at the frontiers of human progress.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 6%
Last updated:
For AI agents: llms.txt
Industries Embryo Ventures invests in
Stages Embryo Ventures invests in
Countries Embryo Ventures invests in
Round sizes
Round size
- Seed
- $1.5M–$3.2M
Investment Focus
Industry
- Health Care 3 (17%)
- CleanTech 2 (11%)
- Pharmaceutical 2 (11%)
- SaaS 1 (6%)
- Travel 1 (6%)
Stage
- Seed 7 (39%)
- Pre-Seed 3 (17%)
- Angel 1 (6%)
- Funding Round 1 (6%)
- Venture - Series Unknown 1 (6%)
Country
- United Kingdom 9 (50%)
- United States 1 (6%)
- The Netherlands 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Gladys is a revolutionary social care software platform set to transform the caregiving landscape through innovation, empowerment, and direct connections. With a commitment to cutting out intermediaries, Gladys brings local carers, helpers, and families together in a seamless digital ecosystem. Led by a seasoned co-founding team with extensiveexperience in the sector, Gladys is uniquely positioned to address the challenges faced by the social care industry. As a female-led tech business based in the UK, Gladys is dedicated to driving change, simplifying processes, and enhancing the quality of care provided to vulnerable individuals. Backed by venture capital firm Antler, Gladys is poised to redefine social care, empowering caregivers and families. | $2M / Seed / Oct 13, 2025 | ||
| OSSTEC is bringing advanced technology to the operating room with metal 3D printed bone healing implants. The orthopaedic implants emulate natural bone structure and address high failure rates of existing implants, keeping patients who suffer with osteoarthritis healthy, active and enjoying life. | $3.2M / Seed / Mar 30, 2025 | ||
| Gladys is a revolutionary social care software platform set to transform the caregiving landscape through innovation, empowerment, and direct connections. With a commitment to cutting out intermediaries, Gladys brings local carers, helpers, and families together in a seamless digital ecosystem. Led by a seasoned co-founding team with extensiveexperience in the sector, Gladys is uniquely positioned to address the challenges faced by the social care industry. As a female-led tech business based in the UK, Gladys is dedicated to driving change, simplifying processes, and enhancing the quality of care provided to vulnerable individuals. Backed by venture capital firm Antler, Gladys is poised to redefine social care, empowering caregivers and families. | Seed / Jul 25, 2024 | ||
| Ostique provides products for ostomates that rebalance your everyday life | $762.6K / Venture - Series Unknown / Jan 26, 2024 | ||
| STAXY is creating a sustainable future for travel by providing corporates and organisations with a mobility-as-a-service platform that enables employees and communities access to low-cost and convenient modes of transport. | Pre-Seed / Apr 28, 2023 | ||
| OSSTEC is bringing advanced technology to the operating room with metal 3D printed bone healing implants. The orthopaedic implants emulate natural bone structure and address high failure rates of existing implants, keeping patients who suffer with osteoarthritis healthy, active and enjoying life. | $1.5M / Seed / Mar 30, 2023 | ||
| Calla Lily Clinical Care is a women’s health focused B-Corp that has developed the proprietary Callavid® platform for intravaginal drug delivery. Initial target indications are in fertility and pregnancy, where the company seeks to offer the world’s first drug-device combo product to prevent miscarriages, and for IVF luteal phase support. Callavid®can also deliver live biotherapeutics (LBPs) to reduce recurrent Bacterial Vaginosis, cutting antibiotic usage and reducing the spread of antimicrobial resistance (AMR). Further use-cases include HRT for menopause use cases, and effective medical sample collection (Lilyvid™ device) to facilitate the next generation of biomarker-based diagnostic tests for endometriosis and a wide range of other conditions. The company’s devices are built upon underlying technology named a TIME Magazine Best Invention of the Year. | $590.6K / Angel / Oct 31, 2022 | ||
| TasteIndex offers a simple system for consumers to find the products they love, with a recommendation system that is based on sensory intent science, chemical data, and AI. TasteIndex leverages the power of pattern recognition to effectively match supply and demand and is on a mission to become a global standard on taste for food and beverageproducts. | Seed / Apr 01, 2022 | ||
| Laka is an InsurTech startup that develops a peer-to-peer bicycle insurance platform to protect bikes. It provides actual coverage by a community of like-minded people who are collectively given a fair price that covers theft, vandalism, damage, and loss as well as provides recovery advice and treatments. | Seed / Dec 31, 2021 | ||
| BioLumen is a nutritional technology company that develops a patented dietary fiber technology platform that reduces the negative effect of a diet heavy in processed foods. BioLumen's technology is composed of insoluble dietary fiber matrix covered with a blend of food ingredients created from the latest drug delivery system research.Thecompany's product, a nutraceutical, focuses on high risk individuals with prediabetes to help manage blood sugar levels, protect their liver from excess sugar and feed their gut microbiome, delivering health benefits.BioLumen was founded on 2018 and is headquartered in San Francisco, California. | Seed / Apr 15, 2021 | ||
| See all 18 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Embryo Ventures invest in?
Embryo Ventures invests primarily in Health Care, CleanTech and Pharmaceutical startups, most often at Seed and Pre-Seed stage. Most of the 18 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Embryo Ventures's check size?
Embryo Ventures typically joins rounds of $1.5M–$3.2M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Embryo Ventures participates in.
When did Embryo Ventures last invest?
The most recent investment recorded for Embryo Ventures closed in Oct 2025. Shizune tracks 18 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
